Ab Initio Biotherapeutics
Ab Initio Biotherapeutics operates as an antigen-discovery company. Its proprietary antigen discovery platform allows for targeting multi-transmembrane proteins such as GPCRs and facilitates antibody generation relevant to a wide array of therapeutic indications including neurological, cardiovascular, endocrine and gastrointestinal disorders.
Industries
Nr. of Employees
small (1-50)
Ab Initio Biotherapeutics
South San Francisco, California, United States, North America
Patents
Products
Antibody Optimization
A process that uses engineered animals with human Ig transgenes to generate antibodies with optimal binding characteristics for therapeutic use.
OmniAb Discovery Platform
A platform providing access to diverse antibody repertoires and high-throughput screening technologies for discovering next-generation therapeutics using transgenic animals.
Phenotypic Sampling of the Immune Repertoire
A method to identify antibodies in immunized animals using single B-cell screening, allowing for the recovery of desired mAb clones and efficient immune repertoire sampling.
OmniRat
A transgenic rat platform generating human antibodies for therapeutic development, including monospecific and bispecific antibodies.
OmniMouse
A transgenic mouse platform delivering fully human antibodies using standard mouse-based protocols.
Diving Deeper into Immune Repertoires
An approach to expand candidate pools by further phenotypic screening and using NGS data to explore antibody repertoires for related sequences.
Antibody Optimization
A process that uses engineered animals with human Ig transgenes to generate antibodies with optimal binding characteristics for therapeutic use.
OmniAb Discovery Platform
A platform providing access to diverse antibody repertoires and high-throughput screening technologies for discovering next-generation therapeutics using transgenic animals.
Phenotypic Sampling of the Immune Repertoire
A method to identify antibodies in immunized animals using single B-cell screening, allowing for the recovery of desired mAb clones and efficient immune repertoire sampling.
OmniRat
A transgenic rat platform generating human antibodies for therapeutic development, including monospecific and bispecific antibodies.
OmniMouse
A transgenic mouse platform delivering fully human antibodies using standard mouse-based protocols.
Diving Deeper into Immune Repertoires
An approach to expand candidate pools by further phenotypic screening and using NGS data to explore antibody repertoires for related sequences.